Literature DB >> 9034683

Leukaemia inhibitory factor: induction in the early phase of allergic contact dermatitis.

J C Szepietowski1, R C McKenzie, S G Keohane, C Walker, R D Aldridge, J A Hunter.   

Abstract

It has been suggested that leukaemia inhibitory factor (LIF), may be involved in the pathogenesis of cutaneous inflammation. In 5 patients with previously proven contact allergy to nickel, LIF mRNA and protein expression were assessed by reverse transcription-polymerase chain reaction and immunohistochemistry in 5% nickel sulfate patch test biopsies 24 h after application of the patch. Control specimens were obtained from non-tested and vehicle-tested skin from the same individuals. LIF mRNA expression was significantly increased in nickel-tested skin compared with both vehicle-tested (p = 0.045) and non-tested skin (p = 0.041). All biopsies showed similar patterns of LIF immunoreactivity, with no significant differences between nickel-tested, vehicle-tested and non-tested skin. Immunostaining was cytoplasmic and was present in the epidermis and hair follicles. No dermal staining was observed. This study suggests that LIF may play a role in the early phase of allergic contact dermatitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034683     DOI: 10.1111/j.1600-0536.1997.tb00917.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  1 in total

1.  Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine.

Authors:  L R Banner; P H Patterson; A Allchorne; S Poole; C J Woolf
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.